Celcuity CELC
NASDAQ CELC
$94.61 -1.82 (-1.89%)
As of: Sep 4, 2026 · 12:49 PM EDT

Celcuity (CELC) Tax Rate (2018 - 2020)

Celcuity's (CELC) quarterly Tax Rate came in at 78.01% in Q4 2020, down 739.0% YoY from 12.21% in Q1 2020, and down 8.66% on a QoQ basis from 85.41% in Q4 2019.

Analysis

Celcuity (CELC) Tax Rate (2018 - 2020) Analysis & Trends

Celcuity (CELC) has 3 years of Tax Rate data on file, last reported at 78.01% in Q4 2020.

  • Quarterly Tax Rate fell 739.0% year-over-year to 78.01% in Q4 2020, while the trailing twelve-month figure through Jun 2021 was 9.11% (down 964.0% YoY) and the FY2025 annual result came in at 21.0%, up 2160.0% from the prior year.
  • Tax Rate slipped to 78.01% in Q4 2020, from 85.41% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 86.07% in Q4 2018 to a low of 78.01% in Q4 2020.
  • A 3-year average of 83.16% and a median of 85.41% in 2019 frame the typical range for Tax Rate.
  • Annual changes were most pronounced in 2019 — Tax Rate slumped 66 bps — and 2020, when it slumped 739 bps.
  • Tracing CELC's Tax Rate over 3 years: stood at 86.07% in 2018, then slipped by 1 bps to 85.41% in 2019, then fell by 9 bps to 78.01% in 2020.
  • The last three Tax Rate figures came in at 78.01% (Q4 2020), 85.41% (Q4 2019), and 86.07% (Q4 2018), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 15.11%
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -10.89%
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -1.96%
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 24.15%
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 7.49%
8 Royalty Pharma 28.52 Bn 27.68 Bn - -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -16.71%
10 Celcuity 5.19 Bn 5.19 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 78.01%
Dec 31, 2019 85.41%
Dec 31, 2018 86.07%